Publications in collaboration with researchers from Hospital Universitario Son Espases (28)

2025

  1. Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma

    Blood Advances, Vol. 9, Núm. 3, pp. 571-582

  2. Development and Comparison of Reference Equations for the Six-Minute Walk Test in Spanish Healthy Adults Aged 45–85 Years

    Archivos de Bronconeumologia

2024

  1. Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study)

    Neuro-oncology, Vol. 26, Núm. 11, pp. 2074-2083

  2. MARRTA: Risk matrix in advanced radiotherapy

    Physica Medica, Vol. 127

  3. National Diagnostic Reference Levels for Standard Descending Thoracic Endovascular Aortic Repair and Optimisation Strategies

    European Journal of Vascular and Endovascular Surgery, Vol. 68, Núm. 2, pp. 210-217

  4. Re-irradiation for progressive Diffuse Intrinsic Pontine Glioma (DIPG): The Spanish experience

    EJC Paediatric Oncology, Vol. 4

2023

  1. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  2. Maximal Respiratory Pressure Reference Equations in Healthy Adults and Cut-off Points for Defining Respiratory Muscle Weakness

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 813-820

  3. Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 4, pp. 881-892

2022

  1. Consensus on early detection of disease progression in patients with multiple sclerosis

    Frontiers in Neurology, Vol. 13

  2. High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

    The Lancet Oncology, Vol. 23, Núm. 5, pp. 671-681

  3. The limit of physiological adaptation of the right ventricle to endurance training

    Revista Andaluza de Medicina del Deporte, Vol. 15, Núm. 4, pp. 157-164

  4. Update on the diagnosis of encephalitis

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 4, pp. 247-257

2021

  1. 10-Year Results of a Phase III Randomized Trial of High-Dose Radiotherapy and Risk-Adapted Androgen Deprivation in Localized Prostate Cancer

    International journal of radiation oncology, biology, physics, Vol. 111, Núm. 3, pp. S77

  2. Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial

    Radiotherapy and Oncology, Vol. 160, pp. 115-119

2020

  1. Relevance of quantification in brain PET studies with 18F-FDG

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 3, pp. 184-192

  2. Safety in radiation oncology: transposition of directive 2013/59/EURATOM in the Spanish Radiation Oncology Departments—recommendations for its adequate and effective application

    Clinical and Translational Oncology, Vol. 22, Núm. 11, pp. 2097-2102

  3. Updating national diagnostic reference levels for interventional cardiology and methodological aspects

    Physica Medica, Vol. 70, pp. 169-175

2019

  1. Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1707-1711

2018

  1. Amyloid PET in neurodegenerative diseases with dementia

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 6, pp. 397-406